Liang-Kang Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Liang-Kang Huang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Cheng-Keng Chuang
Division of Urology, Department of Surgery, Chang Gung Memorial Hospital
3 shared publications - Chun-Te Wu
Department of Urology, Linkou Chang Gung Memorial Hospital, and School of Medicine, Chang Gung University, Guishan, TaoYuan, Taiwan
3 shared publications - Hung-Cheng Kan
Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan (R.O.C.)
3 shared publications - I.-Hung Shao
Department of Urology, Linkou Chang Gung Memorial Hospital, and School of Medicine Chang Gung University Guishan Taoyuan Taiwan
3 shared publications - Kai-Jie Yu
Division of Urology, Department of Surgery, LinKou Chang Gung Memorial Hospital, Taoyuan, Taiwan
3 shared publications - Po-Hung Lin
School of Medicine, College of Medicine Chang Gung University Taoyuan Taiwan
3 shared publications
Latest Publications
- 10 July 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-12
Predicting hemorrhagic complications in robotic-assisted partial nephrectomy for renal tumors: simplifying risk assessment with tumor diameter and depth
Purpose Robotic-assisted partial nephrectomy has emerged as the standard surgical procedure for managing localized kidney cancers, with bleeding risk being a primary clinical consideration. This investigation seeks to establish simple predictive indicators for hemorrhage-related adverse events. Materials and methods We performed a retrospective review of sequential patients undergoing robotic-assisted partial nephrectomy at a single tertiary medical center. Patient records and radiographic studies were analyzed to obtain clinical parameters. Tumor characteristics (size, infiltration depth, and standardized nephrometry measurements) were assessed by an experienced radiologist. Bleeding-related outcomes included surgical blood loss, transfusion requirements, reoperation, and need for angiographic intervention. Predictive factors for hemorrhagic events were examined statistically. Results The study included 260 participants. Median nephrometry scores were 8.5 (PADUA) and 7.0 (RENAL). The average tumor size measured 39.1 mm with a mean penetration depth of 2.02 mm, and the median renal ischemia duration was 25.5 min. Mean operative hemorrhage volume was 147 ml. Transfusion was administered to 12.7% of cases, with 3.5% experiencing significant hemorrhagic complications. Tumor size independently predicted both intraoperative bleeding and transfusion needs, while invasion depth showed a strong association with severe bleeding events. Conclusions Compared to comprehensive nephrometry systems, basic tumor measurements (diameter and depth) effectively anticipate bleeding risks. These straightforward parameters enable clinicians to identify high-risk patients and initiate preventive measures.
- 10 July 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-12
Predicting hemorrhagic complications in robotic-assisted partial nephrectomy for renal tumors: simplifying risk assessment with tumor diameter and depth
Purpose Robotic-assisted partial nephrectomy has emerged as the standard surgical procedure for managing localized kidney cancers, with bleeding risk being a primary clinical consideration. This investigation seeks to establish simple predictive indicators for hemorrhage-related adverse events. Materials and methods We performed a retrospective review of sequential patients undergoing robotic-assisted partial nephrectomy at a single tertiary medical center. Patient records and radiographic studies were analyzed to obtain clinical parameters. Tumor characteristics (size, infiltration depth, and standardized nephrometry measurements) were assessed by an experienced radiologist. Bleeding-related outcomes included surgical blood loss, transfusion requirements, reoperation, and need for angiographic intervention. Predictive factors for hemorrhagic events were examined statistically. Results The study included 260 participants. Median nephrometry scores were 8.5 (PADUA) and 7.0 (RENAL). The average tumor size measured 39.1 mm with a mean penetration depth of 2.02 mm, and the median renal ischemia duration was 25.5 min. Mean operative hemorrhage volume was 147 ml. Transfusion was administered to 12.7% of cases, with 3.5% experiencing significant hemorrhagic complications. Tumor size independently predicted both intraoperative bleeding and transfusion needs, while invasion depth showed a strong association with severe bleeding events. Conclusions Compared to comprehensive nephrometry systems, basic tumor measurements (diameter and depth) effectively anticipate bleeding risks. These straightforward parameters enable clinicians to identify high-risk patients and initiate preventive measures.
- Open Access
Replacement Instead of Discontinuation of Bacillus Calmette-Guérin Instillation in Non-Muscle-Invasive Bladder Cancer
Background: To evaluate the efficacy of intravesical chemotherapy replacement in patients with intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC), who underwent bacillus Calmette-Guérin (BCG) instillation but discontinued due to global shortages or toxicity of BCG. Methods: This retrospective study included patients with intermediate- and high-risk NMIBC who received BCG intravesical instillation. Those who discontinued the treatment were divided into the pure BCG group and chemotherapy replacement group. Comparisons between these groups were performed. The primary endpoint was bladder recurrence-free survival (RFS). Results: A total of 480 patients were included. Baseline characteristics were similar between groups, but the total instillation times were higher in the chemotherapy replacement group than in the pure BCG group (n = 14.9 vs. 10.5). The chemotherapy replacement group had a better three-year RFS (p = 0.022). On multivariate analysis, the pure BCG group had significantly increased all-time and 3-year recurrences (hazard ratio 2.015 and 2.148) compared to the chemotherapy replacement group. Conclusions: Chemotherapy replacement has a better three-year RFS than no instillation in patients with intermediate- and high-risk NMIBC who received BCG instillation but facing treatment stoppage.
Open AccessReplacement Instead of Discontinuation of Bacillus Calmette-Guérin Instillation in Non-Muscle-Invasive Bladder Cancer
Background: To evaluate the efficacy of intravesical chemotherapy replacement in patients with intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC), who underwent bacillus Calmette-Guérin (BCG) instillation but discontinued due to global shortages or toxicity of BCG. Methods: This retrospective study included patients with intermediate- and high-risk NMIBC who received BCG intravesical instillation. Those who discontinued the treatment were divided into the pure BCG group and chemotherapy replacement group. Comparisons between these groups were performed. The primary endpoint was bladder recurrence-free survival (RFS). Results: A total of 480 patients were included. Baseline characteristics were similar between groups, but the total instillation times were higher in the chemotherapy replacement group than in the pure BCG group (n = 14.9 vs. 10.5). The chemotherapy replacement group had a better three-year RFS (p = 0.022). On multivariate analysis, the pure BCG group had significantly increased all-time and 3-year recurrences (hazard ratio 2.015 and 2.148) compared to the chemotherapy replacement group. Conclusions: Chemotherapy replacement has a better three-year RFS than no instillation in patients with intermediate- and high-risk NMIBC who received BCG instillation but facing treatment stoppage.
- Open Access
- 8 January 2023
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (1) , 126
Recognition of Postoperative Cystography Features by Artificial Intelligence to Predict Recovery from Postprostatectomy Urinary Incontinence: A Rapid and Easy Way to Predict Functional Outcome
Purpose: Post-operative cystography has been used to predict the recovery of postprostatectomy urinary incontinence (PPI) in patients with localized prostate cancer. This study aimed to validate the predictive value of cystography for PPI and utilize a deep learning model to identify favorable and unfavorable features. Methods: Medical records and cystography images of patients who underwent robotic-assisted radical prostatectomy for localized prostate cancer were retrospectively reviewed. Specific cystography features, including anastomosis leakage, a downward bladder neck (BN), and the bladder neck angle, were analyzed for the prediction of PPI recovery. Favorable and unfavorable patterns were categorized based on the three cystography features. The deep learning model used for transfer learning was ResNet 50 and weights were trained on ImageNet. We used 5-fold cross-validation to reduce bias. After each fold, we used a test set to confirm the model’s performance. Result: A total of 170 consecutive patients were included; 31.2% experienced immediate urinary continence after surgery, while 93.5% achieved a pad-free status and 6.5% were still incontinent in the 24 weeks after surgery. We divided patients into a fast recovery group (≤4 weeks) and a slow recovery group (>4 weeks). Compared with the slow recovery group, the fast recovery group had a significantly lower anastomosis leakage rate, less of a downward bladder neck, and a larger bladder neck angle. Test data used to evaluate the model’s performance demonstrated an average 5-fold accuracy, sensitivity, and specificity of 93.75%, 87.5%, and 100%, respectively. Conclusions: Postoperative cystography features can predict PPI recovery in patients with localized prostate cancer. A deep-learning model can facilitate the identification process. Further validation and exploration are required for the future development of artificial intelligence (AI) in this field.
- 8 January 2023
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (1) , 126
Open AccessRecognition of Postoperative Cystography Features by Artificial Intelligence to Predict Recovery from Postprostatectomy Urinary Incontinence: A Rapid and Easy Way to Predict Functional Outcome
Purpose: Post-operative cystography has been used to predict the recovery of postprostatectomy urinary incontinence (PPI) in patients with localized prostate cancer. This study aimed to validate the predictive value of cystography for PPI and utilize a deep learning model to identify favorable and unfavorable features. Methods: Medical records and cystography images of patients who underwent robotic-assisted radical prostatectomy for localized prostate cancer were retrospectively reviewed. Specific cystography features, including anastomosis leakage, a downward bladder neck (BN), and the bladder neck angle, were analyzed for the prediction of PPI recovery. Favorable and unfavorable patterns were categorized based on the three cystography features. The deep learning model used for transfer learning was ResNet 50 and weights were trained on ImageNet. We used 5-fold cross-validation to reduce bias. After each fold, we used a test set to confirm the model’s performance. Result: A total of 170 consecutive patients were included; 31.2% experienced immediate urinary continence after surgery, while 93.5% achieved a pad-free status and 6.5% were still incontinent in the 24 weeks after surgery. We divided patients into a fast recovery group (≤4 weeks) and a slow recovery group (>4 weeks). Compared with the slow recovery group, the fast recovery group had a significantly lower anastomosis leakage rate, less of a downward bladder neck, and a larger bladder neck angle. Test data used to evaluate the model’s performance demonstrated an average 5-fold accuracy, sensitivity, and specificity of 93.75%, 87.5%, and 100%, respectively. Conclusions: Postoperative cystography features can predict PPI recovery in patients with localized prostate cancer. A deep-learning model can facilitate the identification process. Further validation and exploration are required for the future development of artificial intelligence (AI) in this field.